Cambridge's Akcea discloses layoffs after FDA drug rejection
September 06, 2018 at 17:13 PM EDT
The FDA ruled against approving the company's rare disease drug, called Waylivra, last week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.